# Biodesix (BDSX) — Analyst Forecast

BDSX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bdsx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 7 | 0 | 0 | 7 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $35.00 | $37.67 | $40.00 | 3 |

Last price $24.71 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | TD Cowen | Maintained | Buy | $40.00 |
| Sep 25, 2026 | HC Wainwright & Co. | Maintained | Buy | $38.00 |
| Aug 10, 2026 | Canaccord Genuity | Maintained | Buy | $35.00 |
| Aug 6, 2026 | HC Wainwright & Co. | Maintained | Buy | $27.00 |
| Jun 25, 2026 | Roth Capital | Initiated Coverage | Buy | $32.00 |
| Jun 18, 2026 | Canaccord Genuity | Maintained | Buy | $27.00 |
| Jun 15, 2026 | HC Wainwright & Co. | Initiated Coverage | Buy | $26.00 |
| May 5, 2026 | Canaccord Genuity | Maintained | Buy | $22.00 |
| Feb 27, 2026 | William Blair | Upgraded | Market Perform → Outperform | — |
| Feb 17, 2026 | Canaccord Genuity | Maintained | Buy | $20.00 |
| Sep 19, 2025 | Canaccord Genuity | Maintained | Buy | $20.00 |
| May 21, 2025 | Scotiabank | Maintained | Sector Outperform | $2.00 |
| May 14, 2025 | William Blair | Downgraded | Outperform → Market Perform | — |
| May 14, 2025 | Canaccord Genuity | Maintained | Buy | $1.50 |
| May 14, 2025 | Lake Street | Maintained | Buy | $2.00 |
| May 14, 2025 | Craig-Hallum | Maintained | Buy | $1.50 |
| Apr 29, 2025 | Canaccord Genuity | Maintained | Buy | $2.50 |
| Sep 16, 2024 | Scotiabank | Initiated Coverage | Sector Outperform | $3.00 |
| Jul 26, 2024 | Craig-Hallum | Initiated Coverage | Buy | $3.00 |
| May 13, 2024 | TD Cowen | Initiated Coverage | Buy | $2.80 |

## Frequently Asked Questions

### What is the price target for BDSX stock?

The average 12-month analyst price target for Biodesix (BDSX) is $37.67, with a high estimate of $40.00 and a low of $35.00, across 3 analysts.

### Is BDSX a buy, sell, or hold?

Analysts covering Biodesix currently average a Buy rating: 7 buy, 0 hold and 0 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for BDSX?

The average price target of $37.67 implies 52.43% upside from the last price of $24.71.

### What is the latest analyst rating on BDSX?

On Oct 13, 2026, TD Cowen maintained Biodesix at Buy with a price target of $40.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).